share_log

D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9

D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9

D. Boral Capital開始覆蓋美第奇新星生物技術,並給予買入評級,宣佈股價目標爲$9
Benzinga ·  2024/12/02 21:30  · 評級/大行評級

D. Boral Capital analyst Jason Kolbert initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $9.

D. Boral Capital 分析師 Jason Kolbert 對美第奇新星生物技術(納斯達克:MNOV)進行覆蓋,給予買入評級,並宣佈價格目標爲9美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論